Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
CD25-targeted antibody-drug conjugate
DRUG CLASS:
CD25-targeted antibody-drug conjugate
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
ADCT-301 (3)
ADCT-301 (3)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
IL2RA expression
Non-Hodgkin’s Lymphoma
IL2RA expression
Non-Hodgkin’s Lymphoma
ADCT-301
Sensitive: D – Preclinical
ADCT-301
Sensitive
:
D
ADCT-301
Sensitive: D – Preclinical
ADCT-301
Sensitive
:
D
IL2RA expression
Colorectal Cancer
IL2RA expression
Colorectal Cancer
ADCT-301
Sensitive: D – Preclinical
ADCT-301
Sensitive
:
D
ADCT-301
Sensitive: D – Preclinical
ADCT-301
Sensitive
:
D
ALK positive
Non-Hodgkin’s Lymphoma
ALK positive
Non-Hodgkin’s Lymphoma
ADCT-301
Sensitive: D – Preclinical
ADCT-301
Sensitive
:
D
ADCT-301
Sensitive: D – Preclinical
ADCT-301
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.